SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-08-026843
Filing Date
2008-05-01
Accepted
2008-05-01 16:16:25
Documents
1
Period of Report
2008-04-30

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION bdn55257_bdn3jvc.html 4  
1 MAIN DOCUMENT DESCRIPTION bdn55257_bdn3jvc.xml 4 2389
  Complete submission text file 0001209191-08-026843.txt   4194
Mailing Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043
Business Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043 650.944.7000
Alexza Pharmaceuticals Inc. (Issuer) CIK: 0001344413 (see all company filings)

IRS No.: 770567768 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043
Business Address 650.944.7000
Cassella James V (Reporting) CIK: 0001353528 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51820 | Film No.: 08794956